These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19402768)

  • 1. Carnosine, diabetes and Alzheimer's disease.
    Hipkiss AR
    Expert Rev Neurother; 2009 May; 9(5):583-5. PubMed ID: 19402768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carnosine--biological activity and perspectives in pharmacotherapy].
    Zieba R
    Wiad Lek; 2007; 60(1-2):73-9. PubMed ID: 17607973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinorganic chemistry of Alzheimer's disease.
    Kepp KP
    Chem Rev; 2012 Oct; 112(10):5193-239. PubMed ID: 22793492
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic links between diabetes and Alzheimer's disease.
    Maher PA; Schubert DR
    Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnosine: physiological properties and therapeutic potential.
    Gariballa SE; Sinclair AJ
    Age Ageing; 2000 May; 29(3):207-10. PubMed ID: 10855900
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carnosine and diseases of central nervous system].
    Shen Y; Hu WW; Chen Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):199-203. PubMed ID: 17443912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transition from physiological to pathophysiological indices as exemplified by amyloidosis in periodic disease, non-insulin-dependent diabetes mellitus, and Alzheimer's disease].
    Piruzian LA; Leksina LA
    Fiziol Cheloveka; 2009; 35(1):107-20. PubMed ID: 19323434
    [No Abstract]   [Full Text] [Related]  

  • 8. Convergence of atherosclerosis and Alzheimer's disease.
    Korantzopoulos P; Kokkoris S; Siogas K; Galaris D
    Lancet; 2004 Jun; 363(9426):2092. PubMed ID: 15207975
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes linked to higher risk of Alzheimer's disease.
    Health News; 2004 Jul; 10(7):13. PubMed ID: 15239165
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 11. [New therapeutic strategies in Alzheimer's disease].
    Salamaca-Gómez F
    Gac Med Mex; 2002; 138(5):493-4. PubMed ID: 12404733
    [No Abstract]   [Full Text] [Related]  

  • 12. Helping Alzheimer's patients sleep.
    Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):1-2. PubMed ID: 19408407
    [No Abstract]   [Full Text] [Related]  

  • 13. Let''s try erythropoietin in Alzheimer's disease.
    Modabbernia A; Ashrafi M; Modabbernia MJ
    Med Hypotheses; 2010 Aug; 75(2):270-1. PubMed ID: 20385448
    [No Abstract]   [Full Text] [Related]  

  • 14. Agitation in Alzheimer's disease: no to donepezil. Psycho-behavioural measures are better option.
    Prescrire Int; 2008 Oct; 17(97):212. PubMed ID: 19536942
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer's disease.
    Ozen M; Karaahmet F; Tezcan ME; Bulut N; Altundag K
    Med Hypotheses; 2007; 68(1):231-2. PubMed ID: 16962721
    [No Abstract]   [Full Text] [Related]  

  • 16. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease.
    Scott LE; Page BD; Patrick BO; Orvig C
    Dalton Trans; 2008 Dec; (45):6364-7. PubMed ID: 19002321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper in Alzheimer's disease: too much or too little?
    Quinn JF; Crane S; Harris C; Wadsworth TL
    Expert Rev Neurother; 2009 May; 9(5):631-7. PubMed ID: 19402774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and Alzheimer disease.
    Franco KS; Bronson D
    Arch Neurol; 2005 Feb; 62(2):330; author reply 330-1. PubMed ID: 15710867
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice.
    Arendash GW; Cox AA; Mori T; Cracchiolo JR; Hensley KL; Roberts LJ
    Neuroreport; 2009 Aug; 20(12):1087-92. PubMed ID: 19543132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.